Selective Vitamin D Receptor Activation as Anti-Inflammatory Target in Chronic Kidney Disease

Paricalcitol, a selective vitamin D receptor (VDR) activator used for treatment of secondary hyperparathyroidism in chronic kidney disease (CKD), has been associated with survival advantages, suggesting that this drug, beyond its ability to suppress parathyroid hormone, may have additional beneficia...

Descripción completa

Detalles Bibliográficos
Autores principales: Donate-Correa, J., Domínguez-Pimentel, V., Méndez-Pérez, M. L., Muros-de-Fuentes, M., Mora-Fernández, C., Martín-Núñez, E., Cazaña-Pérez, V., Navarro-González, J. F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2014
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913352/
https://www.ncbi.nlm.nih.gov/pubmed/24511210
http://dx.doi.org/10.1155/2014/670475

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3913352/
https://www.ncbi.nlm.nih.gov/pubmed/24511210
http://dx.doi.org/10.1155/2014/670475

Ejemplares similares